Home › Funds › Principal Global Investors › CPRX
Principal Global Investors position in CPRX
CATALYST PHARMACEUTICALS INC
Latest position (Q2 2026)683.27K sh
Reported value held$21.48M
Portfolio Weight0.01%
First reportedQ4 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 118.68K | $803.00K | New |
| Q1 2022 | 78.80K | $653.00K | Reduce |
| Q2 2022 | 73.00K | $512.00K | Reduce |
| Q3 2022 | 608.17K | $7.80M | Add |
| Q4 2022 | 632.03K | $11.76M | Add |
| Q1 2023 | 613.50K | $10.17M | Reduce |
| Q2 2023 | 580.99K | $7.81M | Reduce |
| Q3 2023 | 577.83K | $6.75M | Reduce |
| Q4 2023 | 578.31K | $9.72M | Hold |
| Q1 2024 | 649.44K | $10.35M | Add |
| Q2 2024 | 639.23K | $9.90M | Reduce |
| Q3 2024 | 575.95K | $11.45M | Reduce |
| Q4 2024 | 600.49K | $12.53M | Add |
| Q1 2025 | 617.51K | $14.97M | Add |
| Q2 2025 | 623.97K | $13.54M | Add |
| Q3 2025 | 639.12K | $12.59M | Add |
| Q4 2025 | 683.68K | $15.96M | Add |
| Q1 2026 | 675.98K | $16.74M | Reduce |
| Q2 2026 | 683.27K | $21.48M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CPRX
- BlackRock Inc 19.16M sh · $602.16M · Q2 2026
- Vanguard Group 8.43M sh · $196.81M · Q4 2025
- JPMorgan Chase & Co 3.17M sh · $99.89M · Q2 2026
- Geode Capital Management 3.15M sh · $99.03M · Q2 2026
- Morgan Stanley 2.76M sh · $86.76M · Q2 2026
- Renaissance Technologies 2.14M sh · $67.14M · Q2 2026
- Janus Henderson Group 2.00M sh · $49.52M · Q1 2026
- UBS Group AG 1.45M sh · $45.69M · Q2 2026
- Northern Trust Corp 1.33M sh · $41.82M · Q2 2026
- Bank of America Corp 1.31M sh · $41.22M · Q2 2026
- Goldman Sachs Group 1.19M sh · $37.53M · Q2 2026
- Charles Schwab Investment Management 1.16M sh · $36.44M · Q2 2026